Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Scientists reveal how miRNAs shape cancer and offer new paths for treatment

Review explores how microRNAs (miRNAs) interact in cancer development, their potential in diagnosis, and innovative therapeutic strategies, including overcoming chemotherapy resistance.

20 Oct 2024

Researchers uncover the potential of JAK inhibitors to treat life-threatening skin disease

Researchers identified Janus kinase inhibitors as a promising treatment for the severe drug-induced skin condition toxic epidermal necrolysis, by analyzing patient biopsies with deep visual proteomics.

17 Oct 2024

Study links healthy diet to reduced progression of low-risk prostate cancer

In a peer-reviewed study believed to be the first of its kind published, a research team led by Johns Hopkins Medicine provides scientific evidence that a healthy diet may reduce the chance of low risk prostate cancer progressing to a more aggressive state in men undergoing active surveillance - a clinical option in which men with lower risk cancer are carefully monitored for progression in lieu of treatments that could have undesired side effects or complications.

17 Oct 2024

Newly identified 'headspin hole' affects breakdancers’ scalp health

Breakdancers may be at risk of developing a condition caused by repeatedly doing a cardinal move of their practice and performance - the headspin - warn doctors in the journal BMJ Case Reports.

12 Oct 2024

CKMT2 regulates mitochondrial function and energy metabolism in type 2 diabetes

Creatine kinase M2 (CKMT2) plays a key role in mitochondrial dysfunction in type 2 diabetes, affecting energy metabolism in skeletal muscle.

10 Oct 2024

Early blood test can predict treatment response and survival prospects in metastatic prostate cancer

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond to treatment and survive the longest.

7 Oct 2024

Innovative blood test for lung cancer offers faster and more sensitive diagnosis

A new way of diagnosing lung cancer with a blood draw is 10 times faster and 14 times more sensitive than earlier methods, according to University of Michigan researchers.

3 Oct 2024

AI-powered blood test promises early detection of ovarian cancer

A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help screen women for early signs of ovarian cancer, according to a study by researchers at the Johns Hopkins Kimmel Cancer Center in collaboration with several other institutions in the United States and Europe.

30 Sep 2024

Owlstone Medical launches Breath Biopsy VOC Atlas® to unlock disease biomarkers in human breath

The Breath Biopsy VOC Atlas offers a comprehensive catalog of volatile organic compounds, enhancing understanding of breath biomarkers in health and disease.

From Owlstone Medical Ltd 30 Sep 2024

New AI technology promises enhanced breast cancer detection

Women worldwide could see better treatment with new AI technology which enables better detection of damaged cells and more precisely predict the risk of getting breast cancer, shows new research from the University of Copenhagen.

25 Sep 2024

UCLA develops largest collection of patient-derived organoids for sarcoma research

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify therapies that are most likely to work for each individual patient.

20 Sep 2024

Anti-fibrotic drug shows promise in breast cancer

The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute to tumor cell growth, HER2. Despite this common trait, the development of HER2-negative cancers varies among patients, so one goal is to be able to classify tumors in more detail and thus determine the best treatment for each case.

20 Sep 2024

New biopsy technique reduces infection risk in prostate cancer detection

A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches.

19 Sep 2024

Brain measurements prove more accurate in predicting mild cognitive impairment

University of Oklahoma researchers recently published a study showing that several measurements of the brain, including blood flow and the brain's ability to compensate for the lack of it, are better predictors of mild cognitive impairment than risk factors like hypertension and high cholesterol.

16 Sep 2024

PDX engraftment predicts high recurrence and poor survival in triple-negative breast cancer

Researchers examine the association between patient-derived xenograft with recurrence and survival rates in triple negative breast cancer patients.

11 Sep 2024

New imaging technique could help identify kidney injury from cancer immunotherapy

Immune checkpoint inhibitors (ICIs) are a class of immunotherapy that have revolutionized the treatment of cancer.

6 Sep 2024

Breakthrough technology detects cancer mutant genes with unprecedented sensitivity

Dr. Min-young Lee and Dr. Sung-gyu Park of the Advanced Bio and Healthcare Materials Research Division at KIMS have developed a technology that can detect cancer mutant genes in blood with the world's highest sensitivity of 0.000000001% based on plasmonic nanomaterials for optical signal amplification.

6 Sep 2024

Unfold AI outperforms conventional methods in prostate cancer risk prediction

A recently published study in BJUI Compass confirms the groundbreaking potential of Unfold AI™, an FDA-cleared artificial intelligence (AI) algorithm developed by Avenda Health, a leader in personalized prostate cancer care.

6 Sep 2024

Researchers make breakthrough in predicting the prognosis of triple-negative breast cancer

Scientists at Huntsman Cancer Institute at the University of Utah (the U), the National Cancer Institute-designated cancer center for the Mountain West, have made a significant breakthrough in predicting the prognosis of triple-negative breast cancer (TNBC), a particularly aggressive disease.

5 Sep 2024

Introducing a blood-based test for minimally invasive detection of IDH1 mutant gliomas

Glioma represents the most common central nervous system cancer in adults. The current classification scheme uses molecular alterations, particularly IDH1.R132H, to stratify lesions into distinct prognostic groups.

30 Aug 2024

Biopsy News and Research

Further Reading

Scientists reveal how miRNAs shape cancer and offer new paths for treatment

Researchers uncover the potential of JAK inhibitors to treat life-threatening skin disease

Study links healthy diet to reduced progression of low-risk prostate cancer

Newly identified 'headspin hole' affects breakdancers’ scalp health

CKMT2 regulates mitochondrial function and energy metabolism in type 2 diabetes

Early blood test can predict treatment response and survival prospects in metastatic prostate cancer

Innovative blood test for lung cancer offers faster and more sensitive diagnosis

AI-powered blood test promises early detection of ovarian cancer

Owlstone Medical launches Breath Biopsy VOC Atlas® to unlock disease biomarkers in human breath

New AI technology promises enhanced breast cancer detection

UCLA develops largest collection of patient-derived organoids for sarcoma research

Anti-fibrotic drug shows promise in breast cancer

New biopsy technique reduces infection risk in prostate cancer detection

Brain measurements prove more accurate in predicting mild cognitive impairment

PDX engraftment predicts high recurrence and poor survival in triple-negative breast cancer

New imaging technique could help identify kidney injury from cancer immunotherapy

Breakthrough technology detects cancer mutant genes with unprecedented sensitivity

Unfold AI outperforms conventional methods in prostate cancer risk prediction

Researchers make breakthrough in predicting the prognosis of triple-negative breast cancer

Introducing a blood-based test for minimally invasive detection of IDH1 mutant gliomas

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News